SARS-CoV-2 protein E
From Proteopedia
(Difference between revisions)
(10 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | <SX viewer='molstar' load='' size='340' side='right' caption='' scene=''> | + | <SX viewer='molstar' load='7k3g' size='340' side='right' caption='PDB-ID 7K3G: Solid state NMR struture' scene=''> |
- | + | __TOC__ | |
- | + | ||
==Overview== | ==Overview== | ||
The envelope (E) protein of Sars-CoV and Sars-CoV-2 is the smallest of the viruse’s structural proteins. It is an integral membrane protein embedded in the envelope, but also localized in the ER, golgi and ERGIC, once a host cell has been infected <ref name="rasmol1"> J. Nieto-Torres, M. DeDiego, E. Álvarez, J. Jiménez-Guardeño, J. Regla-Nava, M. Llorente, et al.: Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein, Virology, 2011 </ref>. | The envelope (E) protein of Sars-CoV and Sars-CoV-2 is the smallest of the viruse’s structural proteins. It is an integral membrane protein embedded in the envelope, but also localized in the ER, golgi and ERGIC, once a host cell has been infected <ref name="rasmol1"> J. Nieto-Torres, M. DeDiego, E. Álvarez, J. Jiménez-Guardeño, J. Regla-Nava, M. Llorente, et al.: Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein, Virology, 2011 </ref>. | ||
- | The structure of the envelope protein of Sars-CoV has so far only been modeled on | + | The structure of the envelope protein of Sars-CoV has so far only been modeled based on nuclear magnetic resonance (NMR) data. Yet, modeling the 3D structure of Sars-CoV-2 E protein turns out to be quite challenging. Only the amino acid sequence of Sars-CoV-2 E protein is known, yet. Hence, the structure and function of Sars-CoV-2 E protein can only be prdicted by comparison with the Sars-CoV E protein. |
Sequence alignements of the envelope proteins of both viruses, consisting of 76 amino acids in Sars-CoV and 75 amino acids in Sars-CoV-2 <ref name="rasmol2"> M. Bianchi, D. Benvenuto, M. Giovanetti, S. Angeletti, M. Ciccozzi, S. Pascarella: Sars-CoV-2 Envelope and Membrane proteins: differences from closely related proteins linked to cross-species transmission?, Preprint, 2020 </ref> <ref name="rasmol3"> D. Schoeman, B. Fielding: Coronavirus envelope protein: current knowlege, Virology Journal, 2019 </ref>, demonstrate a 91% sequence homology <ref name="rasmol2"/>. Functional and structural comparison of Sars-CoV-2 with the existing knowlege about Sars-CoV could provide a good prediction of the E protein’s role in causing Covid-19. | Sequence alignements of the envelope proteins of both viruses, consisting of 76 amino acids in Sars-CoV and 75 amino acids in Sars-CoV-2 <ref name="rasmol2"> M. Bianchi, D. Benvenuto, M. Giovanetti, S. Angeletti, M. Ciccozzi, S. Pascarella: Sars-CoV-2 Envelope and Membrane proteins: differences from closely related proteins linked to cross-species transmission?, Preprint, 2020 </ref> <ref name="rasmol3"> D. Schoeman, B. Fielding: Coronavirus envelope protein: current knowlege, Virology Journal, 2019 </ref>, demonstrate a 91% sequence homology <ref name="rasmol2"/>. Functional and structural comparison of Sars-CoV-2 with the existing knowlege about Sars-CoV could provide a good prediction of the E protein’s role in causing Covid-19. | ||
Line 18: | Line 17: | ||
Several posttranslational modifications are proven to modify the E protein of Sars-CoV and other viruses. Palmitoylation is the addition of palmitic acid to cystein residues increasing the protein’s hydrophobicity. Hence, palmitoylation of E assists in membrane association and anchoring. In addition, the modification is suggested to co-localize the virus to the golgi membrane by operating as an additional targeting sequence. | Several posttranslational modifications are proven to modify the E protein of Sars-CoV and other viruses. Palmitoylation is the addition of palmitic acid to cystein residues increasing the protein’s hydrophobicity. Hence, palmitoylation of E assists in membrane association and anchoring. In addition, the modification is suggested to co-localize the virus to the golgi membrane by operating as an additional targeting sequence. | ||
Ubiquitination assays with Sars-CoV E protein proves that its “ubiqutination status inversely correlates to its stability and half life”<ref name="rasmol3"/>. Accordingly, ubiquitination might function as a negative regulation of E protein levels and consequntly of viral production to achieve the best viral titre. | Ubiquitination assays with Sars-CoV E protein proves that its “ubiqutination status inversely correlates to its stability and half life”<ref name="rasmol3"/>. Accordingly, ubiquitination might function as a negative regulation of E protein levels and consequntly of viral production to achieve the best viral titre. | ||
- | Another modification shown to occure in Sars-CoV E protein adds oligiosaccharid fragments to asparagine residues in a certain motif (Asn-X-Ser/Thr) which is also involved in the sequence of Sars-CoV | + | Another modification shown to occure in Sars-CoV E protein adds oligiosaccharid fragments to asparagine residues in a certain motif (Asn-X-Ser/Thr) which is also involved in the sequence of Sars-CoV-2 envelope protein. This modification, namely glycosilation, recruits chaperone proteins of the host cell that aid in the correct folding of new synthesized viral proteins. In Sars-CoV residue N66 embedded in the motif Asn-Ser-Ser was discovered to be glycosilated, while the other potential glycosilation target N48 also located in a suitable motif (Asn-Val-Ser) had no attached oligiosaccharid. Both motifs are also found in Sars-CoV-2. Experimantal data suggest that glycosilation of N66 might prevent oligiomerization of E to promote various processes induced by monomeric E protein <ref name="rasmol3"/>. |
==Function== | ==Function== | ||
===Viral assembly=== | ===Viral assembly=== | ||
- | Viral assembly means the process of gathering around all the viral molecules (proteins and genome) to form a virus like particle (VLP) resulting in the release of a fully matured virus. The assembly is located | + | Viral assembly means the process of gathering around all the viral molecules (proteins and genome) to form a virus like particle (VLP) resulting in the release of a fully matured virus. The assembly is located at the ERGIC where the VLP buds into the lumen of ERGIC and follows the way through the host cell’s secretory pathway. Several experiments confirm the involvement of the envelope protein in the assembly process. Nevertheless, lack of E in Sars-CoV infected cells still does not stop VLP production completely, but rather cripples viral maturation. In Sars corona viruses lacking the E protein a deviant morphology of virions being pinched and elongated has been observed. The absence of E furthermore arrests virus trafficing and blocks its secretion, thus resulting in a lower number of mature virions, but more vesicles carrying granular material of the aborted assembly. The result is a high rate of propagation-incompetent virions<ref name="rasmol3"/>. |
===Membrane curvature=== | ===Membrane curvature=== | ||
Line 31: | Line 30: | ||
===Ion channel activity=== | ===Ion channel activity=== | ||
- | The envelope protein in its oligiomeric form concentrates hydrophilic residues of the TMD in the inside of the channel structure | + | The envelope protein in its oligiomeric form concentrates hydrophilic residues of the TMD in the inside of the channel structure, whereas the hydrophobic amino acids orientate towards the phospholipids of the membrane <ref name="rasmol"> Y. Ye, B. Hogue: Role of the coronavirus E viroporin protein transmembrane |
domain in virus assembly, Virology Journal, 2007 </ref>. Thus, specific structural features are required for anchoring the viroporin to the membrane, namely an amphipathic α-helix as well as basic positively charged residues. The anchoring process is mediated by electrostatic interactions between the positive amino acids and the negatively charged phospholipids. Pores of Sars-CoV E protein mainly favour the transport of Na+ and K+, but were also found to be permeable for Ca2+. Ion selectivity is suggested to be generated by residue N15 used as a sort of filter <ref name="rasmol7"> K. Pervushin, E. Tan, K. Parthasarathy, X. Lin, F. Jiang, D. Yu, A. Vararattanavech, T. Soong, D. Liu, J. Torres: Structure and Inhibition of the SARS Coronavirus Envelope Protein Ion Channel, PloS Pathogens, 2009 </ref> and can further be affected by the charge of the membrane’s lipid head group. | domain in virus assembly, Virology Journal, 2007 </ref>. Thus, specific structural features are required for anchoring the viroporin to the membrane, namely an amphipathic α-helix as well as basic positively charged residues. The anchoring process is mediated by electrostatic interactions between the positive amino acids and the negatively charged phospholipids. Pores of Sars-CoV E protein mainly favour the transport of Na+ and K+, but were also found to be permeable for Ca2+. Ion selectivity is suggested to be generated by residue N15 used as a sort of filter <ref name="rasmol7"> K. Pervushin, E. Tan, K. Parthasarathy, X. Lin, F. Jiang, D. Yu, A. Vararattanavech, T. Soong, D. Liu, J. Torres: Structure and Inhibition of the SARS Coronavirus Envelope Protein Ion Channel, PloS Pathogens, 2009 </ref> and can further be affected by the charge of the membrane’s lipid head group. | ||
Ion channels involving the inactivating mutations N15A and V25F in the TMD display to regain their original virulence by incorporating other single mutations at the same position (A15D, F25D) or multiple changes at several positions nearby (L19A, F20 L, F26 L, L27S, T30I, L37R). | Ion channels involving the inactivating mutations N15A and V25F in the TMD display to regain their original virulence by incorporating other single mutations at the same position (A15D, F25D) or multiple changes at several positions nearby (L19A, F20 L, F26 L, L27S, T30I, L37R). | ||
Line 38: | Line 37: | ||
===Intracellular trafficing and targeted localization=== | ===Intracellular trafficing and targeted localization=== | ||
- | The structure of the E protein includes a golgi-targeting signal in the β-coil-β motif of the C-terminus and another one in the N-terminus. Additionally, | + | The structure of the E protein includes a golgi-targeting signal in the β-coil-β motif of the C-terminus and another one in the N-terminus. Additionally, palmitoylation as a posttranslational modification is believed to be involved in the golgi targeting process as well. The targeting signal locates the E protein to the golgi membrane, where E monomers can oligiomerize and form a viroporine in the golgi membrane. From there, the virus acquires the membrane for a new envelope and finds its way through the secretory pathway of the host cell<ref name="rasmol3"/>. |
===Pathogenesis=== | ===Pathogenesis=== | ||
Line 45: | Line 44: | ||
==Protein-Protein-Interactions (PPI)== | ==Protein-Protein-Interactions (PPI)== | ||
- | PPIs of the viruse’s proteins among each other and interactions with host cell proteins occur to deregulate a numerous amount of physiological processes. This causes | + | PPIs of the viruse’s proteins among each other and interactions with host cell proteins occur to deregulate a numerous amount of physiological processes. This causes pathogenesis with several symptoms observed in patients suffering a Sars-CoV infection<ref name="rasmol3"/>. |
===Interactions of E with viral proteins=== | ===Interactions of E with viral proteins=== | ||
- | The small envelope protein unveils to interact with other structural proteins expressed in Sars-CoV as well as with the E protein itself. To form a pentameric viroporin functioning as an ion channel, E monomers interact with their long α-helix in the TMD and oligiomerize. The PPI is mainly mediated by residue V25 and additionally by residue N15 being slightly involved. Both residues are present in Sars-CoV-2 aswell. Interacting with the | + | The small envelope protein unveils to interact with other structural proteins expressed in Sars-CoV as well as with the E protein itself. To form a pentameric viroporin functioning as an ion channel, E monomers interact with their long α-helix in the TMD and oligiomerize. The PPI is mainly mediated by residue V25 and additionally by residue N15 being slightly involved. Both residues are present in Sars-CoV-2 aswell. Interacting with the [[SARS-CoV-2 protein M]] via the C-termini of both at the cytoplasmic side of ERGIC, E aids in VLP formation and release, whereas deletion of both interacting domains reduces VLP formation. The [[SARS-CoV-2 protein N]] seems to interact with the envelope protein independently from M. Nevertheless, co-expression of N with envelope and membrane protein further enhances the VLP production while the exact mechanism and reason of this PPI has not yet been revealed. Both C-termini of E and of N induce this interplay. However, interaction with [[SARS-CoV-2 protein S]] is suggested to be mediated by disulfide bonds between cystein motifs appearing in E and S of Sars-CoV and Sars-CoV-2. A study using tandem affinity purification and mass spectrometry has proved that S is being co-purified with E, even though they did not propose a possible mechanism or function of this PPI <ref name="rasmol10"> E. Álvarez, M. DeDiego, J. Nieto-Torres, J. Jiménez-Guardeño, L. Marcos-Villar, L. Enjuanes: The envelope protein of severe acute respiratory syndrome coronavirus interacts with the non-structural protein 3 and is ubiquitinated, Virology, 2010 </ref>. The last proven viral-intern interaction with E is provided by the structural protein 7a, known to be specifically expressed in Sars-CoV. Protein 7a is present in mature virions and arrests the cell cycle, induces apoptosis and triggers the expression of pro-inflammatory cytokines in the host cell. Yet, the reason of E interacting with 7a and the presence of Protein 7a in Sars-CoV-2 remains unknown<ref name="rasmol3"/>. |
===Interactions of E with host proteins=== | ===Interactions of E with host proteins=== | ||
- | Interactions of the envelope protein with proteins of the host cell are mediated by its PBM domain at the very end of the C-terminus. Among all corona viruses the PBM domain slightly differs, but is identical in the E proteins of Sars-CoV, BatCoV and Sars-CoV-2<ref name="rasmol2"/> containing the four residues DLLV. The motif binds to the PDZ domain of adaptor proteins subsequently bound by other cellular proteins. Followingly, a signalling cascade that possibly | + | Interactions of the envelope protein with proteins of the host cell are mediated by its PBM domain at the very end of the C-terminus. Among all corona viruses the PBM domain slightly differs, but is identical in the E proteins of Sars-CoV, BatCoV and Sars-CoV-2<ref name="rasmol2"/> containing the four residues DLLV. The motif binds to the PDZ domain of adaptor proteins subsequently bound by other cellular proteins. Followingly, a signalling cascade that possibly causes pathogenesis is activated. Five interactions between E and host proteins are reported until now. The anti-apoptotic B-cell lymphoma-extra-large (Bcl-xL) protein is proposed to cause SARS-CoV-induced lymphopenia <ref name="rasmol11"> Y. Yang, Z. Xiong, S. Zhang, Y. Yan, J. Nguyen, B. Ng, et al.: Bcl-xL inhibits T-cell apoptosis induced by expression of SARS coronavirus E protein in the absence of growth factors, Biochemical Journal, 2005 </ref>. Another interacting partner of the envelope protein has been identified as protein associated with C. elegans lin-7 protein 1 (PALS1) which was found to disrupt tight junctions of pulmonary epithelia cells in lungs. This eventually consults in an epithelial barrier breakdown and virions breaking through the alveolar wall causing a systemic infection <ref name="rasmol12"> K. Teoh, Y. Siu, W. Chan, M. Schlüter, C. Liu, J. Peiris, et al.: The SARS coronavirus E protein interacts with PALS1 and alters tight junction formation and epithelial morphogenesis, Mol Biol Cell, 2010 </ref>. ”The breakdown of the epithelial barrier is a hallmark in respiratory distress syndromes” <ref name="rasmol13"> O. Wittekindt: Tight junctions in pulmonary epithelia during lung inflammation, Springer Verlag, 2016 </ref>. Interaction of syntenin with E caused its transportation to the cytoplasm where the protein triggered the overexpression of inflammatory cytokines. A proposed consequence may be an overreaction of immune response effectuating tissue damage, oedema and acute respitory distress syndrome (ARDS) <ref name="rasmol14"> J. Jimenez-Guardeño, J. Nieto-Torres, M. DeDiego, J. Regla-Nava, R. Fernandez-Delgado, C. Castaño-Rodriguez, et al.: The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis, PLoS Pathogens, 2014 </ref>. Both, (Na+/K+) ATPase α-1 subunit and stomatin are cellular proteins that contribute to sustain ionic homeostasis. Interacting with the viruse’s envelope protein may decrease levels and activity of human epithelial sodium channels required for Na+ transport. Changes in the equilibrium affect fluid volume, blood pressure and water homeostasis <ref name="rasmol3"/>. |
Still, according to predictions there are a lot more interacting partners of E that have not yet been uncovered. As it has already been demonstrated by the known interacting partners of E, PPIs play a crucial role in the pathogenesis. Consequently, further research is necessary to perceive more details about the triggered signalling pathways and to discover new interacting proteins. | Still, according to predictions there are a lot more interacting partners of E that have not yet been uncovered. As it has already been demonstrated by the known interacting partners of E, PPIs play a crucial role in the pathogenesis. Consequently, further research is necessary to perceive more details about the triggered signalling pathways and to discover new interacting proteins. | ||
- | + | == See also == | |
- | + | [[Coronavirus_Disease 2019 (COVID-19)]]<br> | |
- | + | [[SARS-CoV-2_virus_proteins]]<br> | |
- | + | [[COVID-19 AlphaFold2 Models]] | |
- | + | ||
</SX> | </SX> | ||
== References == | == References == | ||
<references/> | <references/> |
Current revision
|
References
- ↑ J. Nieto-Torres, M. DeDiego, E. Álvarez, J. Jiménez-Guardeño, J. Regla-Nava, M. Llorente, et al.: Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein, Virology, 2011
- ↑ 2.0 2.1 2.2 M. Bianchi, D. Benvenuto, M. Giovanetti, S. Angeletti, M. Ciccozzi, S. Pascarella: Sars-CoV-2 Envelope and Membrane proteins: differences from closely related proteins linked to cross-species transmission?, Preprint, 2020
- ↑ 3.00 3.01 3.02 3.03 3.04 3.05 3.06 3.07 3.08 3.09 3.10 3.11 3.12 3.13 3.14 3.15 D. Schoeman, B. Fielding: Coronavirus envelope protein: current knowlege, Virology Journal, 2019
- ↑ 4.0 4.1 Y. Li, W. Surya, S. Claudine, J. Torres: Structure of a Conserved Golgi Complex-targeting Signal in Coronavirus Envelope Proteins, The Journal Of Biological Chemistry, 2014
- ↑ Y. Li, W. Surya, S. Claudine, J. Torres: Structure of a Conserved Golgi Complex-targeting Signal in Coronavirus Envelope Proteins, Journal of Biological Chemistry, 2014
- ↑ Y. Ye, B. Hogue: Role of the coronavirus E viroporin protein transmembrane domain in virus assembly, Virology Journal, 2007
- ↑ 7.0 7.1 K. Pervushin, E. Tan, K. Parthasarathy, X. Lin, F. Jiang, D. Yu, A. Vararattanavech, T. Soong, D. Liu, J. Torres: Structure and Inhibition of the SARS Coronavirus Envelope Protein Ion Channel, PloS Pathogens, 2009
- ↑ J. Nieto-Torres, M. DeDiego, C. Verdiá-Báguena, J. Jimenez-Guardeño, J. Regla-Nava, R. Fernandez-Delgado, et al.: Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis, PLoS Pathogens, 2014
- ↑ 9.0 9.1 J. Nieto-Torres, C. Verdiá-Báguena, J. Jimenez-Guardeño, J. Regla-Nava, C. Castaño-Rodriguez, R. Fernandez-Delgado, et al.: Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome, Virology, 2015
- ↑ E. Álvarez, M. DeDiego, J. Nieto-Torres, J. Jiménez-Guardeño, L. Marcos-Villar, L. Enjuanes: The envelope protein of severe acute respiratory syndrome coronavirus interacts with the non-structural protein 3 and is ubiquitinated, Virology, 2010
- ↑ Y. Yang, Z. Xiong, S. Zhang, Y. Yan, J. Nguyen, B. Ng, et al.: Bcl-xL inhibits T-cell apoptosis induced by expression of SARS coronavirus E protein in the absence of growth factors, Biochemical Journal, 2005
- ↑ K. Teoh, Y. Siu, W. Chan, M. Schlüter, C. Liu, J. Peiris, et al.: The SARS coronavirus E protein interacts with PALS1 and alters tight junction formation and epithelial morphogenesis, Mol Biol Cell, 2010
- ↑ O. Wittekindt: Tight junctions in pulmonary epithelia during lung inflammation, Springer Verlag, 2016
- ↑ J. Jimenez-Guardeño, J. Nieto-Torres, M. DeDiego, J. Regla-Nava, R. Fernandez-Delgado, C. Castaño-Rodriguez, et al.: The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis, PLoS Pathogens, 2014